PV pharm branch, vendor, cage 0U9U0
Ended Awarded Last action
- Contract number
- SPE2D826FA3LC
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $59,554
Award facts
- Contract value 100% obligated
- $59,553.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 12, 2026, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $59,553.72 to AmerisourceBergen Drug Corp (CAGE 0U9U0), a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This firm fixed-price delivery order, with an ultimate completion date of January 13, 2026, was awarded on a competitive basis with no set-aside designation. The order was issued under AmerisourceBergen's parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2031. This prime IDC serves as the vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities.
As a critical vendor in the federal pharmaceutical supply chain, AmerisourceBergen maintains an extensive portfolio of medical product deliveries supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's federal contract awards demonstrate capability across multiple therapeutic domains, including diabetes medications, neurological treatments, pain management pharmaceuticals, and specialized medical supplies. The DLA Medical Supply Chain's procurement strategy includes the planned establishment of Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning AmerisourceBergen among key contractors supporting military and federal healthcare operations worldwide.
Quick answers
Who was awarded contract SPE2D826FA3LC?
SPE2D826FA3LC was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on January 12, 2026.
How much is contract SPE2D826FA3LC worth?
The government has obligated $59,554 on SPE2D826FA3LC.
Is contract SPE2D826FA3LC an order under another contract?
Yes. SPE2D826FA3LC is a delivery order under SPE2DX22D0049, an indefinite delivery contract.
Was contract SPE2D826FA3LC competed?
The extent of competition for SPE2D826FA3LC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award